Gut microbes modulate host response to immune checkpoint inhibitor cancer immunotherapy.

Translational cancer research ·Vol. 7 ·No. Suppl 5 ·2018-06-00 ·Pages S608-S610

Liu K, Lu C

Abstract

暂无摘要

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Liu Kebin

Department of Biochemistry and Molecular Biology, Georgia Cancer Center, Medical College of Georgia, Augusta, GA 30912, USA. | Cancer Immunology, Inflammation and Tolerance Program, Georgia Cancer Center, Medical College of Georgia, Augusta, GA 30912, USA.

Lu Chunwan

Conflict of Interest

Footnote Conflicts of Interest: The authors have no conflicts of interest to declare.

References (20)

20 references, click to expand

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.
Science. 2015 Nov 27;350(6264):1079-84 PMID: 26541610
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations.
Sci Transl Med. 2016 Mar 2;8(328):328rv4 PMID: 26936508
T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition.
Science. 2017 Mar 31;355(6332):1428-1433 PMID: 28280247
Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells.
BMC Cancer. 2018 Feb 6;18(1):149 PMID: 29409480
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.
Science. 2018 Jan 5;359(6371):91-97 PMID: 29097494
Proton pump inhibitors alter the composition of the gut microbiota.
Gut. 2016 May;65(5):749-56 PMID: 26719299
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway.
N Engl J Med. 2016 Nov 3;375(18):1767-1778 PMID: 27806234
Structure, function and diversity of the healthy human microbiome.
Nature. 2012 Jun 13;486(7402):207-14 PMID: 22699609
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.
Science. 2018 Jan 5;359(6371):97-103 PMID: 29097493
Microbes and Cancer.
Annu Rev Immunol. 2017 Apr 26;35:199-228 PMID: 28142322
Hallmarks of cancer: the next generation.
Cell. 2011 Mar 4;144(5):646-74 PMID: 21376230
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.
Cancer Cell. 2018 Apr 9;33(4):570-580 PMID: 29634945
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.
Science. 2015 Nov 27;350(6264):1084-9 PMID: 26541606
The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion.
J Natl Cancer Inst. 2017 Jan 28;109(6): PMID: 28131992
Gut dysbiosis and impairment of immune system homeostasis in perinatally-exposed mice to Bisphenol A precede obese phenotype development.
Sci Rep. 2017 Nov 3;7(1):14472 PMID: 29101397
Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.
Science. 1994 Jul 22;265(5171):528-30 PMID: 7518614
PD-1 and its ligands in tolerance and immunity.
Annu Rev Immunol. 2008;26:677-704 PMID: 18173375
Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity.
Cancer Res. 2005 Feb 1;65(3):1089-96 PMID: 15705911
Dysbiosis and the immune system.
Nat Rev Immunol. 2017 Apr;17(4):219-232 PMID: 28260787
A framework for human microbiome research.
Nature. 2012 Jun 13;486(7402):215-21 PMID: 22699610

Article Info

Journal

Translational cancer research

Abbr.

Transl Cancer Res

ISSN

2218-676X

DOI

10.21037/tcr.2018.05.37

Published

2018-06-00

Pages

S608-S610

Language

English

Region

China

NLM ID

101585958

PMCID

PMC6233902

Grants

NCI NIH HHS · R01 CA133085 · United States

NCI NIH HHS · R01 CA182518 · United States

NCI NIH HHS · R43 CA221414 · United States

Corrections

CommentOn

PMID: 29097494

External Links

PubMed source DOI: 10.21037/tcr.2018.05.37 PMC Full Text View journal details

Analysis Services

Gut microbes modulate host response to immune checkpoint inhibitor cancer immunotherapy.

Contact

WeChat Official Account